Our research highlights a significant association of SAMM50-rs2073080 with the progression of NAFLD to hepatic fibrosis, and the in vitro experiments further corroborated these findings. This evidence concerns the gene SAMM50 and metabolic dysfunction-associated steatotic liver disease.